慢性重型肝炎对红细胞沉降率有直接的影响。
Chronic severe hepatitis has direct influence on the erythrocyte sedimentation rate.
目的：探讨慢性重型肝炎红细胞沉降率的水平。
Objective to probe into the level of erythrocyte sedimentation rate with chronic severe hepatitis.
慢性重型肝炎病例在重型肝炎中占83.9%。
Chronic severe hepatitis (CSH) made up 83.9% of total cases of SH.
目的观察慢性重型肝炎患者合并胃黏膜病变的特点。
Objective To investigate the features of the acute gastric mucosal lesion in patients with chronic severe-type hepatitis by endoscopy.
目的：观察中药结肠透析疗法对慢性重型肝炎的临床效果。
Objective: To investigate the effects of colon herbal dialysis in patients with chronic severe hepatitis b.
结论优思弗联合人工肝治疗慢性重型肝炎是安全和有效的。
Conclusion Ursofalk combined with artificial liver treatment and conventional therapy is safe and more effective in treatment of chronic severe hepatitis.
方法：70例慢性重型肝炎患者，随机分成治疗组及对照组。
Methods: 70 patients with chronic severe hepatitis B were divided at random into therapeutic group and control group.
结论中药结肠透析配合综合支持治疗慢性重型肝炎疗效显著。
Conclusions The effects of colon herbal dialysis combining with supportive treatment on chronic severe hepatitis are significant.
结果：6例患者为慢性重型肝炎，2例患者为急性重型肝炎。
Results: The6patients were diagnosised with chronic severe hepatitis, 2patients were diagnosised with acute severe hepatitis.
结果慢性重型肝炎的临床与病理诊断符合率仅为14.58%。
Results The coincidence rate of clinical diagnosis and pathological diagnosis is about 14.58%.
慢性重型肝炎患者MELD评分分值与病情严重程度和预后有关。
The scores of MELD in the chronic severe hepatitis are correlated to the patient's condition and prognosis.
方法：收治慢性重型肝炎88例，随机分为治疗组与对照组。
METHOD: The investigation was carried out among 88 case of CLF who were divided at random into two group:acetylcysteine(treated group) and PGE1(control group).
结论慢性重型肝炎患者肠道菌群严重失调，肠道定植抗力严重受损。
Conclusion Intestinal flora in patients with chronic severe hepatitis were severely disturbed and gut mircobiological colonization resistance was impaired.
目的探讨人工肝支持治疗对慢性重型肝炎患者的临床效果及安全性。
Objective To discuss the clinical effect of artificial liver support system in treating patients with chronic severe hepatitis and the safety.
目的：探讨影响慢性重型肝炎预后的临床及化验室指标，并建立预后模型。
Objective to investigate the clinical and laboratory indexes affecting prognosis of chronic severe hepatitis and construct the prognostic model.
目的：回顾分析血浆置换在慢性重型肝炎治疗中的疗效和影响预后的因素。
Objective to analyze retrospectively the efficacy of plasma exchange on chronic gravis hepatitis and the factors influencing prognosis of the patients.
目的：应用MELD(终末期肝病评分模型)评价慢性重型肝炎的近期预后。
Objective: To evaluate the application of the Model for End-Stage Liver Disease (MELD) in predicting the short-term prognosis in patients with chronic severe viral hepatitis.
目的研究慢性重型肝炎患者肠道菌群的变化及其在这种重危疾病的发病过程中的作用。
Objective To investigate changes in intestinal microflora in patients with chronic severe hepatitis (CSH), and their role in this life-threatening disease.
对45例慢性重型肝炎患者进行红细胞沉降率的检测，并与40例健康对照组进行比较。
Methods The erythrocyte sedimentation rate was detected in 45 cases of chronic severe hepatitis and 40 normal people as control.
目的应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝，进一步评价其安全性和疗效。
Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver.
方法根据血清生化指标与临床症状对患者做出临床诊断，再对慢性重型肝炎肝组织做病理诊断。
Method According to the serum biochemical indicators and clinical symptoms we make out clinical diagnosis and pathological diagnosis for the liver tissue of chronic severe hepatitis.
结论：慢性重型肝炎容易形成门静脉高压，门静脉血流灌注量明显减少，造成肝脏微循环障碍。
Conclusion: Chronic hepatitis gravis is apt to form acute portal hypertension with decreased perfusion of portal vein system thus causing liver in a state of lacking of blood and oxygen.
目的了解十二指肠引流对慢性重型肝炎胆道感染治疗的影响及慢性重型肝炎胆道感染的细菌分布。
Objective To study the influence of duodenal drainage on the treatment of biliary tract infection in chronic severe hepatitis, and the occurrence of the bacterial species.
结果慢性重型肝炎最常见并发症是腹水、电解质紊乱及自发性腹膜炎，发生率均超过5 0 %。
Results the most common complications of CSH were ascites, electrolyte disturbance and spontaneous peritonitis, and their total occurring rate was over 50%.
结论：血浆置换是一种有效的人工肝支持疗法，对慢性重型肝炎有肯定和可靠的辅助支持与治疗作用。
Conclusions: the plasma exchange is a kind of effective artificial liver support therapy, having affirmative and dependable effect of support and treatment in patients with chronic severe hepatitis.
方法26例急慢性重型肝炎患者，每例患者进行MARS人工肝治疗2~3次，每次治疗时间6小时。
Methods26 patients suffering from liver failure received MARS therapy and every patient was treated 2 to 3 times. Treating time was 6 hours each time.
方法整理15 6例慢性重型肝炎患者临床资料进行MELD评分，评估慢性重型肝炎的严重程度和预后。
Methods The clinical da ta of 156 chronic severe hepatitis were collected and evaluated by MELD scoring system to evaluate the chronic severe hepatitis patient's condition and prognosis.
慢性重型肝炎患者肠道菌群的这种变化在其血内毒素水平的升高及肝脏损伤的进一步加重过程中起一定的作用。
Changes in intestinal flora may have a pivotal role in both the elevation of plasma endotoxin and further hepatic lesions resulting in liver failure.
慢性重型肝炎患者肠道菌群的这种变化在其血内毒素水平的升高及肝脏损伤的进一步加重过程中起一定的作用。
Changes in intestinal flora may have a pivotal role in both the elevation of plasma endotoxin and further hepatic lesions resulting in liver failure.
应用推荐